CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 132 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q4 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,619 | +37.3% | 120 | +100.0% | 0.00% | – |
| Q2 2023 | $1,907 | +30.3% | 60 | 0.0% | 0.00% | – |
| Q1 2023 | $1,463 | -26.8% | 60 | -7.7% | 0.00% | – |
| Q4 2022 | $2,000 | 0.0% | 65 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | -77.8% | 65 | -79.6% | 0.00% | – |
| Q2 2022 | $9,000 | -10.0% | 319 | +13.9% | 0.00% | – |
| Q1 2022 | $10,000 | +900.0% | 280 | +803.2% | 0.00% | – |
| Q4 2021 | $1,000 | – | 31 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anchor Investment Management, LLC | 100 | $4,240 | 0.00% |